Form 4 for NKTR NEKTAR THERAPEUTICS
Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0001209191-22-046487 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-17 | 2022-08-16 | NKTR | Thomsen Jillian B. | SVP, CAO | S - Sale | $4.76 | -2,006 | 334.9K | -0.6% | -$9,549 |
| D | 2022-08-17 | 2022-08-15 | NKTR | Thomsen Jillian B. | SVP, CAO | A - Grant | $0.00 | +165.9K | 336.9K | +97% | $0 |
| D | 2022-08-17 | 2022-08-15 | NKTR | Thomsen Jillian B. | SVP, CAO | A - Grant | $0.00 | +331.9K | 331.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-16 | S | D | 2,006 | $4.76 | 334,859 | D | — | — | (F3) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. (F4) This transaction was executed in multiple trades at prices ranging from $4.67 to $4.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer. (F2) This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 6,690 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). |
| 2 | Common | Common Stock | 2022-08-15 | A | A | 165,938 | $0.00 | 336,865 | D | — | — | (F1) Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs were granted in connection with a retention program and the individual's recent promotion. This grant is in lieu of Issuer's usual end-of-year annual performance grants. These RSUs vest over three years from the date of grant in substantially equal quarterly installments based on continued service. (F2) This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 6,690 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). |
| 3 | Derivative | Common Stock | 2022-08-15 | A | A | 331,875 | $0.00 | 331,875 | D | $4.91 · — to 2030-08-14 | 331,875 Common Stock | (F5) Stock options were granted in connection with a retention program and the individual's recent promotion. These stock options are in lieu of the Issuer's usual end-of-year annual performance grants. (F6) Stock options vest over three years from the date of grant in substantially equal monthly installments based on continued service. |